Fiore Michael Henry sold $235K of HQY
Fiore Michael Henry (EVP, CHIEF COMMERCIAL OFFICER) sold 2,470 shares of HEALTHEQUITY, INC. (HQY) at $95.00 ($0.23M total) on 2026-07-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed open-market sale is pre-arranged under a Rule 10b5-1 plan, reducing the likelihood of a strong negative read-through versus discretionary selling.
Market read
Traders may note the insider sale for sentiment, but there is no new operational or financial information to drive repricing.
What to watch
The filing does not state motives beyond the 10b5-1 plan; without concurrent fundamentals (guidance, contracts, litigation), the trading signal is likely sentiment-only.
Background
The article is an SEC Form 4 insider transaction disclosure for HEALTHEQUITY, INC. (HQY).
Ticker impact
SEC Form 4 shows HQY EVP/Chief Commercial Officer Fiore Michael Henry sold 2,470 shares at $95 on a 10b5-1 plan.
Low near-term impact; any reaction is likely muted given the pre-arranged 10b5-1 structure.
The filing is a disclosed open-market sale under a pre-arranged 10b5-1 plan, with no accompanying earnings, guidance, or operational change.
Market effects
Minimal; this is company-specific insider transaction with no sector-wide regulatory or operational trigger.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may still watch for follow-on sales or changes in buying activity.
Key entities
- issuerHEALTHEQUITY, INC.
Subject of the Form 4 insider transaction; EVP/Chief Commercial Officer sold shares under a 10b5-1 plan.
- insiderFiore Michael Henry
EVP, Chief Commercial Officer; reported open-market sale of 2,470 shares at $95.
